Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Outcome Of Board Meeting Held On 10Th November, 2022

 We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Thursday, 10th November, 2022 had considered and approved the following item: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the half year and quarter ended 30th September, 2022 along with the Limited Review Report as issued by M/s Savla & Associates, Statutory Auditors of the Company; copies of which are attached hereunder; The Meeting of the Board Commenced at 3:00 P.M. and concluded at 7:15 P.M.
10-11-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th November, 2022

 We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Thursday, 11th November, 2022 had considered and approved the following item: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the half year and quarter ended 30th September, 2022 along with the Limited Review Report as issued by M/s Savla & Associates, Statutory Auditors of the Company; copies of which are attached hereunder; The Meeting of the Board Commenced at 3:00 P.M. and concluded at 7:15 P.M.
10-11-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 With reference to the captioned subject, this is to bring to your kind attention that the Company has received intimation on 07th November, 2022 from Purva Sharegistry (India) Pvt. Ltd, the Share Transfer Agent of the Company (copy enclosed), pertaining to loss/ misplacement of Original Share Certificate(s) and have requested for issuance of Duplicate Share Certificate(s); in lieu of their Original Share Certificates been lost. Name of the Shareholder: Rajesh Vasant Gandhi and Sanjiv Vasant Gandhi. Number of shares: 700 Folio No. : 000010 Certificate No.(s): 0000929- 0000934 and 0000938
09-11-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for For Approving Unaudited Financial Results Of The Company For The Half Year And Quarter Ended 30Th September, 2022.

 Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 10th November, 2022 at 3.00 p.m. at the Corporate Office of the Company to transact inter - alia the following businesses: 1) To consider, discuss and approve Unaudited Financial Results of the Company for the half year and quarter ended 30th September, 2022. 2) Any other matter with the permission of the Chair
01-11-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Allotment

 This is with reference to the In-principle approval granted by your good office vide letter No. LOD/PREF/VJ/FIP/2646/2022-223 dated September 30, 2022. Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at their meeting held on October 15, 2022 at 7.30 p.m. has allotted 61,993 Equity Shares at a price of Rs. 996.20/- each and 2,51,890 Convertible Warrants at a price of Rs. 996.20/- each by way of Preferential Issue. The requisite details as required in terms of SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015 are provided at Annexure I.
15-10-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder Certificate dated October 04, 2022 received from the SEBI Registered Registrar and Share Transfer Agent (RTA) viz. Purva Sharegistry (India) Pvt. Ltd. for the quarter ended September 30, 2022.
15-10-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Submission of Voting Results and Scrutinizer Report for the 35th Annual General Meeting held on 30th September, 2022 of Fredun Pharmaceuticals Limited
01-10-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 This is to inform you that the 35th Annual General Meeting ('AGM') of Fredun Pharmaceuticals Limited was held on Friday, 30th September, 2022 at 09:00 a.m. (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM), in accordance with the circular(s) issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. In this regard, we enclose herewith the proceedings of the 35th Annual General Meeting of the Company. You are requested to take the above information on record.
30-09-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and 'Code of Conduct for Prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from Saturday, 1st October, 2022 till 48 hours after the end of the Board Meeting wherein; the approval of Un-audited Financial Results for the Quarter and Half-Year ended 30th September, 2022, would be considered, approved and declared. The said information is being notified to all designated persons under the above Regulations.
30-09-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Submission Of Scrutinizer'S Report For Extra Ordinary General Meeting Held On Friday, 23Rd September, 2022

 Please find enclosed herewith the Report as issued by the Scrutinizer for the Remote E-Voting and E-voting conducted for the purpose of Extra Ordinary General Meeting.
23-09-2022
Next Page
Close

Let's Open Free Demat Account